Genomic variant may help predict which patients will experience chemotherapy-induced cardiotoxicity

A team of investigators have discovered a genomic variant that may help clinicians predict which patients will experience cardiotoxicity from a widely used chemotherapy drug, according to a Northwestern Medicine study published in Circulation.
Read More


>>Hollywood's Exotic Secret For Healthy Weight Loss

0 Response to "Genomic variant may help predict which patients will experience chemotherapy-induced cardiotoxicity"

Post a Comment